Evaluation of Hepatic Steatosis in Rodents by Time-Domain Nuclear Magnetic Resonance
Abstract
:1. Introduction
2. Material and Methods
2.1. Animals
2.2. Experimental Design
2.3. Hepatic Triglyceride (TAG) Content
2.4. Statistical Analysis
3. Results
3.1. Body Composition Analyzer Detects Hepatic Steatosis in Rats Treated with High-Fat Diet (HFD) for 12 Weeks
3.2. Body Composition Analyzer Detects Hepatic Steatosis in Genetically Obese Mice Consuming Regular Rodent Chow
3.3. Body Composition Analyzer is Not Accurate for Determining Hepatic Steatosis in Mice Fed HFD
4. Discussion
Author Contributions
Funding
Acknowledgments
Conflicts of Interest
References
- Angulo, P. Obesity and nonalcoholic fatty liver disease. Nutr. Rev. 2007, 65, S57–S63. [Google Scholar] [CrossRef]
- Calzadilla Bertot, L.; Adams, L.A. The Natural Course of Non-Alcoholic Fatty Liver Disease. Int. J. Mol. Sci. 2016, 17, 774. [Google Scholar] [CrossRef]
- Younossi, Z.M.; Koenig, A.B.; Abdelatif, D.; Fazel, Y.; Henry, L.; Wymer, M. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 2016, 64, 73–84. [Google Scholar] [CrossRef]
- Chalasani, N.; Younossi, Z.; Lavine, J.E.; Charlton, M.; Cusi, K.; Rinella, M.; Harrison, S.A.; Brunt, E.M.; Sanyal, A.J. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology 2018, 67, 328–357. [Google Scholar] [CrossRef]
- Younossi, Z.; Stepanova, M.; Ong, J.P.; Jacobson, I.M.; Bugianesi, E.; Duseja, A.; Eguchi, Y.; Wong, V.W.; Negro, F.; Yilmaz, Y.; et al. Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates. Clin. Gastroenterol. Hepatol. 2019, 17, 748–755.e3. [Google Scholar] [CrossRef]
- Shulman, G.I. Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic disease. N. Engl. J. Med. 2014, 371, 1131–1141. [Google Scholar] [CrossRef]
- Camporez, J.P.; Wang, Y.; Faarkrog, K.; Chukijrungroat, N.; Petersen, K.F.; Shulman, G.I. Mechanism by which arylamine N-acetyltransferase 1 ablation causes insulin resistance in mice. Proc. Natl. Acad. Sci. USA 2017, 114, E11285–E11292. [Google Scholar] [CrossRef]
- Camporez, J.P.; Kanda, S.; Petersen, M.C.; Jornayvaz, F.R.; Samuel, V.T.; Bhanot, S.; Petersen, K.F.; Jurczak, M.J.; Shulman, G.I. ApoA5 knockdown improves whole-body insulin sensitivity in high-fat-fed mice by reducing ectopic lipid content. J. Lipid Res. 2015, 56, 526–536. [Google Scholar] [CrossRef]
- Van Herck, M.A.; Vonghia, L.; Francque, S.M. Animal Models of Nonalcoholic Fatty Liver Disease—A Starter’s Guide. Nutrients 2017, 9, 1072. [Google Scholar] [CrossRef]
- Kristiansen, M.N.; Veidal, S.S.; Rigbolt, K.T.; Tolbol, K.S.; Roth, J.D.; Jelsing, J.; Vrang, N.; Feigh, M. Obese diet-induced mouse models of nonalcoholic steatohepatitis-tracking disease by liver biopsy. World J. Hepatol. 2016, 8, 673–684. [Google Scholar] [CrossRef]
- Ratziu, V.; Charlotte, F.; Heurtier, A.; Gombert, S.; Giral, P.; Bruckert, E.; Grimaldi, A.; Capron, F.; Poynard, T. Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology 2005, 128, 1898–1906. [Google Scholar] [CrossRef]
- Halldorsdottir, S.; Carmody, J.; Boozer, C.N.; Leduc, C.A.; Leibel, R.L. Reproducibility and accuracy of body composition assessments in mice by dual energy X-ray absorptiometry and time domain nuclear magnetic resonance. Int. J. Body Compos. Res. 2009, 7, 147–154. [Google Scholar]
- Folch, J.; Lees, M.; Sloane Stanley, G.H. A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 1957, 226, 497–509. [Google Scholar]
- Lutz, T.A.; Woods, S.C. Overview of animal models of obesity. Curr. Protoc. Pharmacol. 2012, 58, 5.61.1–5.61.18. [Google Scholar] [CrossRef]
- Metzinger, M.N.; Miramontes, B.; Zhou, P.; Liu, Y.; Chapman, S.; Sun, L.; Sasser, T.A.; Duffield, G.E.; Stack, M.S.; Leevy, W.M. Correlation of X-ray computed tomography with quantitative nuclear magnetic resonance methods for pre-clinical measurement of adipose and lean tissues in living mice. Sensors 2014, 14, 18526–18542. [Google Scholar] [CrossRef]
- Hariri, N.; Thibault, L. High-fat diet-induced obesity in animal models. Nutr. Res. Rev. 2010, 23, 270–299. [Google Scholar] [CrossRef]
- Camporez, J.P.; Jornayvaz, F.R.; Petersen, M.C.; Pesta, D.; Guigni, B.A.; Serr, J.; Zhang, D.; Kahn, M.; Samuel, V.T.; Jurczak, M.J.; et al. Cellular mechanisms by which FGF21 improves insulin sensitivity in male mice. Endocrinology 2013, 154, 3099–3109. [Google Scholar] [CrossRef]
- Camporez, J.P.; Lyu, K.; Goldberg, E.L.; Zhang, D.; Cline, G.W.; Jurczak, M.J.; Dixit, V.D.; Petersen, K.F.; Shulman, G.I. Anti-inflammatory effects of oestrogen mediate the sexual dimorphic response to lipid-induced insulin resistance. J. Physiol. 2019, 597, 3885–3903. [Google Scholar] [CrossRef]
- Picchi, M.G.; Mattos, A.M.; Barbosa, M.R.; Duarte, C.P.; Gandini Mde, A.; Portari, G.V.; Jordao, A.A. A high-fat diet as a model of fatty liver disease in rats. Acta Cir. Bras. 2011, 26, 25–30. [Google Scholar] [CrossRef]
- Song, Z.; Xie, W.; Chen, S.; Strong, J.A.; Print, M.S.; Wang, J.I.; Shareef, A.F.; Ulrich-Lai, Y.M.; Zhang, J.M. High-fat diet increases pain behaviors in rats with or without obesity. Sci. Rep. 2017, 7, 10350. [Google Scholar] [CrossRef]
- Anstee, Q.M.; Goldin, R.D. Mouse models in non-alcoholic fatty liver disease and steatohepatitis research. Int. J. Exp. Pathol. 2006, 87, 1–16. [Google Scholar] [CrossRef] [PubMed]
- Nixon, J.P.; Zhang, M.; Wang, C.; Kuskowski, M.A.; Novak, C.M.; Levine, J.A.; Billington, C.J.; Kotz, C.M. Evaluation of a quantitative magnetic resonance imaging system for whole body composition analysis in rodents. Obesity 2010, 18, 1652–1659. [Google Scholar] [CrossRef] [PubMed]
- Cui, A.; Hu, Z.; Han, Y.; Yang, Y.; Li, Y. Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis. J. Vis. Exp. 2017, 121, e55178. [Google Scholar] [CrossRef]
- AbouRjaili, G.; Shtaynberg, N.; Wetz, R.; Costantino, T.; Abela, G.S. Current concepts in triglyceride metabolism, pathophysiology, and treatment. Metab. Clin. Exp. 2010, 59, 1210–1220. [Google Scholar] [CrossRef]
- Saklayen, M.G. The Global Epidemic of the Metabolic Syndrome. Curr. Hypertens. Rep. 2018, 20, 12. [Google Scholar] [CrossRef] [Green Version]
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Pedroso, J.A.B.; Camporez, J.P.; Belpiede, L.T.; Pinto, R.S.; Cipolla-Neto, J.; Donato, J., Jr. Evaluation of Hepatic Steatosis in Rodents by Time-Domain Nuclear Magnetic Resonance. Diagnostics 2019, 9, 198. https://doi.org/10.3390/diagnostics9040198
Pedroso JAB, Camporez JP, Belpiede LT, Pinto RS, Cipolla-Neto J, Donato J Jr. Evaluation of Hepatic Steatosis in Rodents by Time-Domain Nuclear Magnetic Resonance. Diagnostics. 2019; 9(4):198. https://doi.org/10.3390/diagnostics9040198
Chicago/Turabian StylePedroso, João A.B., João Paulo Camporez, Luciana T. Belpiede, Rafaela S. Pinto, José Cipolla-Neto, and Jose Donato, Jr. 2019. "Evaluation of Hepatic Steatosis in Rodents by Time-Domain Nuclear Magnetic Resonance" Diagnostics 9, no. 4: 198. https://doi.org/10.3390/diagnostics9040198